Skip to content

ER1 – Analysing real-world data – methods, opportunities and challenges

Room:

C

Facilitator:

Stefanie Deuster

Speakers:

Abstract:

 

Link to EAHP Statements

  • Section 4 – Clinical Pharmacy: Statements – 4.3, 4.8
  • Section 5 – Patient Safety and Quality Assurance: Statements – 5.2
  • Section 6 – Education and Research: Statement Statements – 6.4

Abstract

There is an increasing interest in providing real world evidence for healthcare decision-making. Real-World Data may offer unique opportunities to understand the effectiveness, safety, and outcomes of interventions in real world patient populations. Real world evidence derives from analysing this data, which can be generated in randomised clinical trials, prospective or retrospective observational studies, or routinely collected data from clinical practice, electronic health records, health registries, and other sources. Real-World Data can be useful to investigate, for example, the size and characteristics of a specific patient group of interest even over longer time periods, to describe the current standard of care in a patient population, or to identify rare adverse events.

However, there are as well challenges and limitations of using Real-World Data for generating evidence. These challenges include data quality and completeness, selection bias, or possible confounding. Therefore, before relying on Real-World Data in clinical decision making, the suitability and the validity of the data need to be clarified, as well as the question of whether the used data sources really include the information required (both in quantity and quality).

This seminar will provide the basic knowledge on how to define necessary criteria for the use of real-world data for a specific research question. Besides, it will give insight into the adequate design of a research project with real world data, to finally create valuable real-world evidence.

Learning objectives

After the session, the participant should be able to:

  • Outline basic and advanced principles of trial designs with real world data
  • Evaluate the use of routinely collected data and assess its validity and its informative value
  • Assess the potential benefits of using real world data and its challenges and limitations

Educational need addressed

Hospital pharmacists need to know details regarding the judicious use of real world data in order to set up their own research project to create real world evidence.

Keywords

Clinical trials, real world data, real world evidence, big data, study design, evidence-based medicine

×

Deadline extended to July 15th

Problems caused by shortages are serious, threaten patient care and require urgent action.

Help us provide an overview of the scale of the problem, as well as insights into the impact on overall patient care.

Our aim is to investigate the causes of medicine and medical device shortages in the hospital setting,  while also gathering effective solutions and best practices implemented at local, regional, and national levels.

×

Join us in Prague for the 2nd edition of BOOST!

Secure your spot in the Movement for Shortage-Free World

BOOST is where visionaries, innovators, and healthcare leaders come together to tackle one of the biggest challenges in hospital pharmacy—medicine shortages.